The reagent is intended to qualitative detect the COVID-19 IgG and IgM antibody in human serum, plasma or whole blood by colloidal gold immunochromatography assay.
Flexible samples: fingertip whole blood (no need for centrifugation), serum, plasma
Quick screening: results can be interpreted in 15 minutes
Differentiating types: combined detection and distinguishing IgM/IgG antibodies
Manual interpretation: no equipment is needed, easy for general medical institutions to carry out a wide range
The reagent is used for the clinical in vitro qualitative detection of new coronavirus (2019-nCoV) antibodies in human serum, plasma or whole blood.
It is only used as a supplementary test indicator for suspected cases with a negative nucleic acid test of the new coronavirus or used in conjunction with nucleic acid testing in the diagnosis of suspected cases.
It cannot be used as a basis for the diagnosis and exclusion of pneumonia caused by new coronavirus infection, and is not suitable for screening of the general population. Only for medical institutions.
|serum, plasma, whole blood,fingertip blood
|4-30℃, sealed and kept away from light and dry